These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. Computer-extracted MR imaging features are associated with survival in glioblastoma patients. Mazurowski MA; Zhang J; Peters KB; Hobbs H J Neurooncol; 2014 Dec; 120(3):483-8. PubMed ID: 25151504 [TBL] [Abstract][Full Text] [Related]
23. MRI-based machine learning for determining quantitative and qualitative characteristics affecting the survival of glioblastoma multiforme. Jajroudi M; Enferadi M; Homayoun AA; Reiazi R Magn Reson Imaging; 2022 Jan; 85():222-227. PubMed ID: 34687850 [TBL] [Abstract][Full Text] [Related]
24. Differentiation of Pseudoprogression from True Progressionin Glioblastoma Patients after Standard Treatment: A Machine Learning Strategy Combinedwith Radiomics Features from T Sun YZ; Yan LF; Han Y; Nan HY; Xiao G; Tian Q; Pu WH; Li ZY; Wei XC; Wang W; Cui GB BMC Med Imaging; 2021 Feb; 21(1):17. PubMed ID: 33535988 [TBL] [Abstract][Full Text] [Related]
25. Morphologic Features on MR Imaging Classify Multifocal Glioblastomas in Different Prognostic Groups. Pérez-Beteta J; Molina-García D; Villena M; Rodríguez MJ; Velásquez C; Martino J; Meléndez-Asensio B; Rodríguez de Lope Á; Morcillo R; Sepúlveda JM; Hernández-Laín A; Ramos A; Barcia JA; Lara PC; Albillo D; Revert A; Arana E; Pérez-García VM AJNR Am J Neuroradiol; 2019 Apr; 40(4):634-640. PubMed ID: 30923085 [TBL] [Abstract][Full Text] [Related]
26. Positive influence of partial resection on overall survival of patients with overlapping glioblastomas. Quick-Weller J; Tritt S; Baumgarten P; Konczalla J; Kashefiolasl S; Noack A; Tichy J; Seifert V; Marquardt G Clin Neurol Neurosurg; 2017 Oct; 161():22-28. PubMed ID: 28837843 [TBL] [Abstract][Full Text] [Related]
27. Noninvasive O Hajianfar G; Shiri I; Maleki H; Oveisi N; Haghparast A; Abdollahi H; Oveisi M World Neurosurg; 2019 Dec; 132():e140-e161. PubMed ID: 31505292 [TBL] [Abstract][Full Text] [Related]
28. Reliability of noncontrast-enhancing tumor as a biomarker of IDH1 mutation status in glioblastoma. Lasocki A; Tsui A; Gaillard F; Tacey M; Drummond K; Stuckey S J Clin Neurosci; 2017 May; 39():170-175. PubMed ID: 28214089 [TBL] [Abstract][Full Text] [Related]
29. Correlation among pathology, genotype, and patient outcomes in glioblastoma. Homma T; Fukushima T; Vaccarella S; Yonekawa Y; Di Patre PL; Franceschi S; Ohgaki H J Neuropathol Exp Neurol; 2006 Sep; 65(9):846-54. PubMed ID: 16957578 [TBL] [Abstract][Full Text] [Related]
30. Modelling MR and clinical features in grade II/III astrocytomas to predict IDH mutation status. Hyare H; Rice L; Thust S; Nachev P; Jha A; Milic M; Brandner S; Rees J Eur J Radiol; 2019 May; 114():120-127. PubMed ID: 31005161 [TBL] [Abstract][Full Text] [Related]
31. Application of MR morphologic, diffusion tensor, and perfusion imaging in the classification of brain tumors using machine learning scheme. Shrot S; Salhov M; Dvorski N; Konen E; Averbuch A; Hoffmann C Neuroradiology; 2019 Jul; 61(7):757-765. PubMed ID: 30949746 [TBL] [Abstract][Full Text] [Related]
32. Prediction of survival with multi-scale radiomic analysis in glioblastoma patients. Chaddad A; Sabri S; Niazi T; Abdulkarim B Med Biol Eng Comput; 2018 Dec; 56(12):2287-2300. PubMed ID: 29915951 [TBL] [Abstract][Full Text] [Related]
34. High-resolution blood-pool-contrast-enhanced MR angiography in glioblastoma: tumor-associated neovascularization as a biomarker for patient survival. A preliminary study. Puig J; Blasco G; Daunis-I-Estadella J; Alberich-Bayarri A; Essig M; Jain R; Remollo S; Hernández D; Puigdemont M; Sánchez-González J; Mateu G; Wintermark M; Pedraza S Neuroradiology; 2016 Jan; 58(1):17-26. PubMed ID: 26438560 [TBL] [Abstract][Full Text] [Related]
35. Evaluation of Peritumoral Brain Parenchyma Using Contrast-Enhanced 3D Fast Imaging Employing Steady-State Acquisition at 3T for Differentiating Metastatic Brain Tumors and Glioblastomas. Yamamoto J; Kakeda S; Shimajiri S; Nakano Y; Saito T; Ide S; Moriya J; Korogi Y; Nishizawa S World Neurosurg; 2018 Dec; 120():e719-e729. PubMed ID: 30165229 [TBL] [Abstract][Full Text] [Related]
36. Computational Identification of Tumor Anatomic Location Associated with Survival in 2 Large Cohorts of Human Primary Glioblastomas. Liu TT; Achrol AS; Mitchell LA; Du WA; Loya JJ; Rodriguez SA; Feroze A; Westbroek EM; Yeom KW; Stuart JM; Chang SD; Harsh GR; Rubin DL AJNR Am J Neuroradiol; 2016 Apr; 37(4):621-8. PubMed ID: 26744442 [TBL] [Abstract][Full Text] [Related]
37. Radiogenomics of Glioblastoma: Machine Learning-based Classification of Molecular Characteristics by Using Multiparametric and Multiregional MR Imaging Features. Kickingereder P; Bonekamp D; Nowosielski M; Kratz A; Sill M; Burth S; Wick A; Eidel O; Schlemmer HP; Radbruch A; Debus J; Herold-Mende C; Unterberg A; Jones D; Pfister S; Wick W; von Deimling A; Bendszus M; Capper D Radiology; 2016 Dec; 281(3):907-918. PubMed ID: 27636026 [TBL] [Abstract][Full Text] [Related]
38. Machine-learning based radiogenomics analysis of MRI features and metagenes in glioblastoma multiforme patients with different survival time. Liao X; Cai B; Tian B; Luo Y; Song W; Li Y J Cell Mol Med; 2019 Jun; 23(6):4375-4385. PubMed ID: 31001929 [TBL] [Abstract][Full Text] [Related]
39. Preoperative Magnetic Resonance Imaging Radiomics for Predicting Early Recurrence of Glioblastoma. Wang J; Yi X; Fu Y; Pang P; Deng H; Tang H; Han Z; Li H; Nie J; Gong G; Hu Z; Tan Z; Chen BT Front Oncol; 2021; 11():769188. PubMed ID: 34778086 [TBL] [Abstract][Full Text] [Related]